Landsberg Bennett & Dubbaneh’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $4.66M | Sell |
33,880
-600
| -2% | -$82.5K | 0.59% | 47 |
|
|
2021
Q2 | $3.68M | Buy |
34,480
+1,804
| +6% | +$192K | 0.48% | 60 |
|
|
2021
Q1 | $2.99M | Buy |
32,676
+6,480
| +25% | +$592K | 0.43% | 71 |
|
|
2020
Q4 | $2.42M | Buy |
26,196
+7,236
| +38% | +$669K | 0.37% | 79 |
|
|
2020
Q3 | $1.91M | Buy |
18,960
+412
| +2% | +$41.4K | 0.33% | 84 |
|
|
2020
Q2 | $1.85M | Sell |
18,548
-4,908
| -21% | -$488K | 0.38% | 73 |
|
|
2020
Q1 | $1.56M | Buy |
23,456
+2,140
| +10% | +$143K | 0.44% | 61 |
|
|
2019
Q4 | $1.15M | Buy |
21,316
+176
| +0.8% | +$9.51K | 0.27% | 104 |
|
|
2019
Q3 | $785K | Sell |
21,140
-1,260
| -6% | -$46.8K | 0.21% | 107 |
|
|
2019
Q2 | $848K | Buy |
22,400
+7,576
| +51% | +$287K | 0.22% | 108 |
|
|
2019
Q1 | $436K | Buy |
14,824
+140
| +1% | +$4.12K | 0.1% | 162 |
|
|
2018
Q4 | $440K | Buy |
+14,684
| New | +$440K | 0.17% | 141 |
|